<DOC>
	<DOC>NCT01725646</DOC>
	<brief_summary>1. Evaluation of the efficacy of Omacor® in Taiwanese hypertriglyceridemia patients 2. Evaluation of the safety of Omacor® in Taiwanese hypertriglyceridemia patients</brief_summary>
	<brief_title>An Efficacy and Safety Study of Omacor® in Taiwanese Hypertriglyceridemic Patients</brief_title>
	<detailed_description>The primary end point is to evaluate the efficacy and safety of Omacor in Taiwanese hypertriglyceridemia patients.</detailed_description>
	<mesh_term>Hypertriglyceridemia</mesh_term>
	<criteria>Patient has fasting serum TG ≥ 200 mg/dL but no more than 1000 mg/dL Patients had a history of pancreatitis or considered to be at risk of developing pancreatitis Patient had history of a severe cardiovascular event or a revascularization procedure within 6 months prior to randomization</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Hypertriglyceridemia, omega-3-acid ethyl ester</keyword>
</DOC>